Forschungsdatenbank PMU-SQQUID

Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
Zaidat, OO; Castonguay, AC; Fitzsimmons, BF; Woodward, BK; Wang, Z; Killer-Oberpfalzer, M; Wakhloo, A; Gupta, R; Kirshner, H; Eliasziw, M; Thomas Megerian, J; Shetty, S; Yoklavich Guilhermier, M; Barnwell, S; Smith, WS; Gress, DR;
J Stroke Cerebrovasc Dis. 2013; 22(7):1131-1139
Originalarbeiten (Zeitschrift)

Abstract/Keywords Web of Science PubMed Full Text

PMU-Autor/inn/en

Killer-Oberpfalzer Monika
Müller-Thies-Broussalis Erasmia

Abstract

Patients with high-grade symptomatic intracranial stenosis (≥ 70%) have an increased risk of recurrent stroke despite medical treatment with antiplatelet or anticoagulant therapy. Intracranial stenting has been proposed as a viable treatment option for this high-risk patient population; however, evaluation of this therapy in randomized multicenter trials is needed. In this article, we present the design and methods of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial for symptomatic intracranial stenosis.

Useful keywords (using NLM MeSH Indexing)

Adolescent

Adult

Aged

Aged, 80 and over

Clinical Protocols

Constriction, Pathologic/surgery

Female

Humans

Intracranial Arteriosclerosis/complications

Intracranial Arteriosclerosis/surgery*

Male

Middle Aged

Research Design

Stents/adverse effects*

Stroke/etiology

Stroke/prevention*

control*

Find related publications in this database (Keywords)

VISSIT
PHAROS stent
Vitesse stent
stroke
transient ischemic attack
angioplasty
balloon-mounted stent
clinical trial
intracranial stent
intracranial stenosis
ischemic stroke
endovascular